We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
12 hedge funds and large institutions have $22.4M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
9% more funds holding
Funds holding: 11 → 12 (+1)
2% more capital invested
Capital invested by funds: $22.1M → $22.4M (+$369K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.32%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$3.36K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.7K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$410 |
| 4 |
Morgan Stanley
New York
|
+$82 |
Top Sellers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$84.7K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
-$38K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.8K |